3749: 3 Anti-Parasitic Drugs Being Studied for Anti-Cancer Effects: Ivermectin, Mebendazole & Fenbendazole
May 12, 2026
3749: 3 Anti-Parasitic Drugs Being Studied for Anti-Cancer Effects: Ivermectin, Mebendazole & Fenbendazole
May 12, 2026
TWT:
Some of the most controversial discussions in health today involve whether certain anti-parasitic medications could play a role in integrative cancer care.
On today’s show, we explore an emerging and debated area of research looking at three repurposed compounds being studied for potential cancer-support applications.
We break down how drugs like Ivermectin and Mebendazole are being investigated for possible effects on cancer cell structure, metabolism, and programmed cell death pathways.
You’ll also hear why fenbendazole has gained attention in integrative circles, and what the current research actually does and does not show.
Most importantly, we discuss why these compounds are not stand-alone treatments, how they may fit into a broader integrative approach, and why medical supervision and proper context are essential.
So join me on today’s Cabral Concept 3749 as we explore the science, controversy, and integrative perspective behind repurposed anti-parasitic research in cancer. Enjoy the show and let me know your thoughts!
Show Highlights & Big Takeaways
Anti-Parasitic Drugs & Cancer Research: Compounds like Ivermectin, Mebendazole, and fenbendazole are being studied for potential anti-cancer effects, including disrupting cancer cell structure, altering metabolic pathways, and promoting programmed cell death. However, this research is still early and largely experimental.
Early Evidence vs. Clinical Proof: While lab and preclinical studies show interesting mechanisms, such as effects on microtubules, oxidative stress, and tumor signaling pathways, there is currently limited large-scale human clinical evidence to confirm their effectiveness in cancer treatment.
Integrative Use & Medical Supervision: These compounds are not replacements for conventional cancer care such as surgery, chemotherapy, or radiation when appropriate. If they are considered in an integrative setting, they should always be used under medical supervision with careful monitoring, particularly of liver function and overall safety.
Links From This Episode
